论文部分内容阅读
目的研究纤维素性支气管炎的临床治疗体会。方法 124例纤维素性支气管炎患者随机分为研究组和对照组,每组62例,对照组采用针对病因,作抗感染、止血、抗痨、止喘等常规治疗方法;研究组结合患者病情,在常规治疗上加用注射用甲泼尼龙琥珀酸钠(甲强龙)治疗,咯血停止后改用口服甲泼尼龙胶囊(美桌乐),并逐渐减量。观察两组患者的临床疗效,分析临床治疗效果。结果在两组患者中,研究组患者有效率97.8%明显要高于对照组有效率67.6%,两组之间差异具有统计学意义(P<0.05)。结论针对患者采用合理治疗方法 ,较常规治疗会具有更好的疗效,能够提高临床治疗效果,对改善患者临床症状产生积极的影响,值得在实际中推广。
Objective To study the clinical experience of cellulolytic bronchitis. Methods A total of 124 patients with fibrinous bronchitis were randomly divided into the study group and the control group, with 62 cases in each group. The control group was given routine treatment for anti-infection, hemostasis, anti-asthma and anti-asthma. The study group combined with the patient’s condition, In the conventional treatment with injection of methylprednisolone sodium succinate (methylprednisolone) treatment, hemoptysis after the switch to oral methylprednisolone capsules (US table music), and gradually reduced. To observe the clinical efficacy of two groups of patients, analysis of clinical treatment. Results In both groups, the effective rate of the study group was 97.8%, significantly higher than that of the control group (67.6%). The difference between the two groups was statistically significant (P <0.05). Conclusion For patients with reasonable treatment, compared with conventional treatment will have better efficacy, can improve the clinical effect of treatment, to improve the clinical symptoms of patients have a positive impact, it is worth promoting in practice.